Table 4. Percentage of manifestations reported in symptomatic NCC patients with active and inactive lesions.
Reference | Country, year(s) of study | Manifestation | Type of lesions | Percentage | 95%CI |
[14] | Portugal, 1983–92 | Seizures/Epilepsy | Active | 60.5% | 43.4%–76.0% |
[12] | Mexico, 1993–03 | Seizures/Epilepsy | Active | 62.8% | 54.7%–70.4% |
[13] | Portugal, 1983–89 | Seizures/Epilepsy | Inactive | 98.3% | 92.6%–99.5% |
[12] | Mexico, 1993–03 | Seizures/Epilepsy | Inactive | 88.0% | 75.7%–95.5% |
[14] | Portugal 1983–92 | Intracranial Hypertension | Active | 23.7% | 11.1%–40.2% |
[12] | Mexico, 1993–03 | Intracranial Hypertension | Active | 28.8% | 21.9%–36.6% |
[13] | Portugal, 1983–89 | Intracranial Hypertension | Inactive | NA | NA |
[12] | Mexico, 1993–03 | Intracranial Hypertension | Inactive | 0.0% | 0.0%–7.1% |
[14] | Portugal, 1983–92 | Hydrocephalus at CT | Active | 23.7% | 11.4%–40.2% |
[13] | Portugal, 1983–89 | Hydrocephalus at CT | Inactive | 3.5% | 1.0%–8.7% |
[14] | Portugal, 1983–92 | Meningitis | Active | 5.3% | 1.7%–21.4% |
[13] | Portugal, 1983–89 | Meningitis | Inactive | 0.9% | 0.0%–4.7% |